CRISPR/Cas9 Reveals Cancer’s Synthetic Lethal Vulnerabilities – Genetic Engineering & Biotechnology News
|
CRISPR/Cas9 Reveals Cancer's Synthetic Lethal Vulnerabilities
Genetic Engineering & Biotechnology News The CRISPR/Cas9 gene-editing system has been used to identify more than 120 synthetic-lethal gene interactions in cancer cells. These interactions could guide drug developers to new combination therapies that could selectively kill cancer cells, and … |
